{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:52:30Z","timestamp":1793929950768,"version":"4.8.0"},"reference-count":419,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA215134"],"award-info":[{"award-number":["R01CA215134"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","award":["2KL2TR002547"],"award-info":[{"award-number":["2KL2TR002547"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtct.2023.12.001","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T20:01:12Z","timestamp":1708977672000},"page":"349-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-1113","authenticated-orcid":false,"given":"Seth J.","family":"Rotz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel S.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1839-4397","authenticated-orcid":false,"given":"Kristen","family":"Beebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Burkhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Chaudhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elemary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Elsawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9380-4347","authenticated-orcid":false,"given":"Gregory MT","family":"Guilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amado","family":"Karduss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinaida","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Purtill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgani","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Bel\u00e9n Rosales","family":"Ostriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Salooja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Schoemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Seber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Scott","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet S.","family":"Majhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.12.001_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.hemonc.2019.08.002","article-title":"Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations","volume":"13","author":"Aljurf","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0002","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0003","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current Use of and Trends in Hematopoietic Cell Transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbmt.2014.06.035","article-title":"Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors","volume":"21","author":"Hashmi","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0005","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/bmt.2012.258","article-title":"Surviving the cure: long term followup of hematopoietic cell transplant recipients","volume":"48","author":"Majhail","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0006","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbmt.2013.07.020","article-title":"Prevalence of hematopoietic cell transplant survivors in the United States","volume":"19","author":"Majhail","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0007","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0008","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry","volume":"341","author":"Socie","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0009","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.68.8457","article-title":"Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors","volume":"35","author":"Chow","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/9781119612780.ch36","article-title":"Health-related quality of life in adult and pediatric survivors","author":"Mitchell","year":"2021","journal-title":"Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0011","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bbmt.2016.09.025","article-title":"National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report","volume":"23","author":"Hashmi","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0012","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbmt.2016.09.011","article-title":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report","volume":"23","author":"Bevans","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbmt.2016.10.020","article-title":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes","volume":"23","author":"Battiwalla","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbmt.2016.08.018","article-title":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report","volume":"23","author":"Shaw","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2016.09.005","article-title":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report","volume":"23","author":"Morton","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0016","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbmt.2016.10.001","article-title":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report","volume":"23","author":"Gea-Banacloche","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbmt.2016.08.019","article-title":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report","volume":"23","author":"Armenian","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0018","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.bmt.1705243","volume":"37","author":"Rizzo","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0019","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","volume":"12","author":"Rizzo","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5144\/1658-3876.2012.1","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"5","author":"Majhail","year":"2012","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0021","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/bmt.2012.5","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"47","author":"Majhail","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0022","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbmt.2011.12.519","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0023","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5581\/1516-8484.20120032","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"34","author":"Majhail","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.jtct.2023.12.001_bib0024","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ijc.33215","article-title":"Category of evidence and consensus underlying National Comprehensive Cancer Network guidelines: Is there evidence of progress?","volume":"148","author":"Desai","year":"2021","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0025","doi-asserted-by":"crossref","first-page":"e27569","DOI":"10.1002\/pbc.27569","article-title":"Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: A critical review of the literature","volume":"66","author":"Neunert","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0026","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/S2352-3026(20)30404-X","article-title":"Immune cytopenia after allogeneic haematopoietic stem-cell transplantation: challenges, approaches, and future directions","volume":"8","author":"Baur","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0027","article-title":"Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post-transplant setting","author":"Gabelli","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0028","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1158\/1078-0432.CCR-17-3044","article-title":"New Insights from Studies of Clonal Hematopoiesis","volume":"24","author":"Gibson","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtct.2023.12.001_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100744","article-title":"The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation","volume":"46","author":"Nawas","year":"2021","journal-title":"Blood reviews"},{"key":"10.1016\/j.jtct.2023.12.001_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0031","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1200\/JCO.2018.79.2184","article-title":"Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation","volume":"37","author":"Frick","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0032","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0033","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/bmt.2008.99","article-title":"Iron overload in hematopoietic cell transplantation","volume":"41","author":"Majhail","year":"2008","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0034","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/bmt.2015.308","article-title":"Venous thromboembolism in hematopoietic stem cell transplant recipients","volume":"51","author":"Chaturvedi","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0035","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00277-016-2673-3","article-title":"Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis","volume":"95","author":"Zahid","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0036","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.bbmt.2019.06.032","article-title":"Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study","volume":"25","author":"Gangaraju","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0037","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbmt.2017.10.038","article-title":"Venous Thromboembolism in Pediatric Hematopoietic Cell Transplant: A Multicenter Cohort Study","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0038","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/bjh.15866","article-title":"Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study","volume":"186","author":"Gangaraju","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0039","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1182\/bloodadvances.2021004341","article-title":"Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model","volume":"5","author":"Gangaraju","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.001_bib0040","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3324\/haematol.2017.164012","article-title":"Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation","volume":"102","author":"Kekre","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.001_bib0041","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbmt.2018.09.031","article-title":"Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation","volume":"25","author":"Norkin","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0042","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41375-021-01302-5","article-title":"COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey","volume":"35","author":"Ljungman","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.12.001_bib0043","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3324\/haematol.2011.041913","article-title":"Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients","volume":"96","author":"Ljungman","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.001_bib0044","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/cncr.28763","article-title":"Infections Among Long-Term Survivors of Childhood and Adolescent Cancer A Report From the Childhood Cancer Survivor Study","volume":"120","author":"Perkins","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0045","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/bloodadvances.2020001470","article-title":"Late infectious complications in hematopoietic cell transplantation survivors: a population-based study","volume":"4","author":"Foord","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.001_bib0046","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jtct.2020.10.003","article-title":"American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients","volume":"27","author":"Dadwal","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0047","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10096-006-0149-4","article-title":"Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients","volume":"25","author":"Torres","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jtct.2023.12.001_bib0048","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.bmt.1704162","article-title":"Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation","volume":"32","author":"Chen","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2013.10.021","article-title":"Single-day trimethoprim\/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer","volume":"164","author":"Caselli","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.jtct.2023.12.001_bib0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtct.2020.10.004","article-title":"American Society for Transplantation and Cellular Therapy Infectious Disease Guidelines: Preface to the Series","volume":"27","author":"Carpenter","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0051","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jtct.2021.09.010","article-title":"American Society for Transplantation and Cellular Therapy Series:# 4-Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation","volume":"27","author":"Yong","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jtct.2023.12.001_bib0052","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtct.2020.10.001","article-title":"American Society of Transplantation and Cellular Therapy Series, 1: Enterobacterales infection prevention and management after hematopoietic cell transplantation","volume":"27","author":"Satlin","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jtct.2023.12.001_bib0053","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jtct.2020.10.003","article-title":"American Society of Transplantation and Cellular Therapy Series, 2: Management and prevention of aspergillosis in hematopoietic cell transplantation recipients","volume":"27","author":"Dadwal","year":"2021","journal-title":"Transplantation and cellular therapy"},{"key":"10.1016\/j.jtct.2023.12.001_bib0054","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jtct.2021.05.001","article-title":"American Society for Transplantation and Cellular Therapy Series: #3\u2014Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation","volume":"27","author":"Hakki","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jtct.2023.12.001_bib0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jtct.2022.02.013","article-title":"American Society for Transplantation and Cellular Therapy Series: #5\u2014Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant Recipients","volume":"28","author":"Alonso","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jtct.2023.12.001_bib0056","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jtct.2023.01.011","article-title":"American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients","volume":"29","author":"Neofytos","year":"2023","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jtct.2023.12.001_bib0057","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report","volume":"21","author":"Carpenter","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0058","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0059","unstructured":"Pallasch T, Shulman ST, Rowley AH, et al. Prevention of Infective Endocarditis: Guidelines From the American Heart Association: A. 2007."},{"key":"10.1016\/j.jtct.2023.12.001_bib0060","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.bbmt.2019.03.017","article-title":"Comparing a Neutropenic Diet to a Food Safety-Based Diet in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation","volume":"25","author":"Taggart","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0061","first-page":"27","article-title":"Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States","author":"Bhatt","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jtct.2023.12.001_bib0062","first-page":"54.e51","article-title":"Return-to-School Practices for Pediatric Hematopoietic Cell Transplantation Recipients during the COVID-19 Pandemic","volume":"28","author":"Bhatt","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0063","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jtct.2023.12.001_bib0064","series-title":"International standards for hematopoietic cellular therapy product collection, processing, and administration","year":"2018"},{"key":"10.1016\/j.jtct.2023.12.001_bib0065","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2016.01.023","article-title":"Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report","volume":"22","author":"Chow","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0066","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2015-12-550475","article-title":"How I vaccinate blood and marrow transplant recipients","volume":"127","author":"Carpenter","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0067","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clinical infectious diseases"},{"key":"10.1016\/j.jtct.2023.12.001_bib0068","series-title":"Advisory Committee on Immunization Practices (ACIP) General Best Guidance for Immunization","year":"2022"},{"key":"10.1016\/j.jtct.2023.12.001_bib0069","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjh.17918","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients","volume":"196","author":"Shem-Tov","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.09.002","article-title":"Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)","author":"Dioverti","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0071","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bjh.18312","article-title":"Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant","volume":"198","author":"Murray","year":"2022","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0072","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1200\/JCO.2008.16.8450","article-title":"Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis","volume":"27","author":"Raanani","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100596","article-title":"CAR-T\u2013and a side order of IgG, to go?\u2013Immunoglobulin replacement in patients receiving CAR-T cell therapy","volume":"38","author":"Hill","year":"2019","journal-title":"Blood reviews"},{"key":"10.1016\/j.jtct.2023.12.001_bib0074","first-page":"65","article-title":"Hypogammaglobulinemia due to CAR T-cell therapy","author":"Doan","year":"2018","journal-title":"Pediatric blood & cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"Hayden","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0076","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.2019004000","article-title":"How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0077","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41571-020-00456-y","article-title":"Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells","volume":"18","author":"Shalabi","year":"2021","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0078","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0079","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2009.254","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective PREFACE","volume":"44","author":"Tomblyn","year":"2009","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0081","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4103\/ijo.IJO_2016_20","article-title":"Update on ocular graft-versus-host disease","volume":"69","author":"Nair","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0082","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","article-title":"Ocular findings after allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Tabbara","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0083","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.sjopt.2013.06.007","article-title":"Ocular manifestations of graft-versus-host disease","volume":"27","author":"Nassar","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0084","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41409-018-0340-0","article-title":"Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT","volume":"54","author":"Inamoto","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0085","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41409-018-0339-6","article-title":"Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT","volume":"54","author":"Inamoto","year":"2019","journal-title":"Bone marrow transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0086","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/cncr.21752","article-title":"Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study","volume":"106","author":"Gurney","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0087","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bmt.1705490","article-title":"Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials","volume":"38","author":"Pavletic","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0088","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00784-010-0450-6","article-title":"Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD","volume":"15","author":"Meier","year":"2011","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jtct.2023.12.001_bib0089","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","article-title":"Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning","volume":"117","author":"Majhail","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0091","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0092","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/bmt.2010.163","article-title":"High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan","volume":"46","author":"Chen","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0093","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2011.23","article-title":"Secondary solid tumors after allogeneic hematopoietic SCT in Japan","volume":"47","author":"Yokota","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0094","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study","volume":"105","author":"Curtis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/annonc\/mdt558","article-title":"Continuing increased risk of oral\/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease","volume":"25","author":"Atsuta","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0096","first-page":"223","volume":"23","author":"Elad","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0097","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbmt.2012.04.009","article-title":"Extensive dental caries in patients with oral chronic graft-versus-host disease","volume":"18","author":"Castellarin","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0098","first-page":"181","article-title":"Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children","volume":"103","author":"Holtta","year":"2005","journal-title":"Cancer-Am Cancer Soc"},{"key":"10.1016\/j.jtct.2023.12.001_bib0099","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/TP.0b013e31820c85fa","article-title":"Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients","volume":"91","author":"Solh","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bbmt.2019.09.034","article-title":"Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation","volume":"26","author":"Wenger","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0101","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","article-title":"An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome","volume":"183","author":"Panoskaltsis-Mortari","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0102","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood-2016-08-693507","article-title":"How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"129","author":"Williams","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0103","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.200212-1468OC","article-title":"Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation","volume":"168","author":"Chien","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0104","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.2009.1018","article-title":"Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation","volume":"302","author":"Williams","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2023.12.001_bib0105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbmt.2014.02.011","article-title":"Screening with Spirometry Is a Useful Predictor of Later Development of Noninfectious Pulmonary Syndromes in Patients Undergoing Allogeneic Stem Cell Transplantation","volume":"20","author":"Thompson","year":"2014","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0106","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/bmt.2013.17","article-title":"Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight\u2013new perspectives?","volume":"48","author":"Ditschkowski","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0107","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.755878","article-title":"Pulmonary Complications After Pediatric Stem Cell Transplant","volume":"11","author":"Fitch","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0108","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1182\/blood-2002-06-1813","article-title":"Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants","volume":"102","author":"Freudenberger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0109","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/bmt.2013.116","article-title":"Pre-transplant risk factors for cryptogenic organizing pneumonia\/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation","volume":"48","author":"Nakasone","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1703142","article-title":"Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation","volume":"28","author":"Afessa","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0111","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0112","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3324\/haematol.2016.150250","article-title":"Late effects of blood and marrow transplantation","volume":"102","author":"Inamoto","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.001_bib0113","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11239-020-02344-9","article-title":"Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation","volume":"51","author":"Rotz","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtct.2023.12.001_bib0114","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-155-1-201107050-00004","article-title":"Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation","volume":"155","author":"Chow","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0115","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/bloodadvances.2018019117","article-title":"Prediction of cardiovascular disease among hematopoietic cell transplantation survivors","volume":"2","author":"Armenian","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.001_bib0116","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26600","article-title":"Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant","volume":"64","author":"Rotz","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0117","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/blood-2011-06-358226","article-title":"Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation","volume":"118","author":"Armenian","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0118","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3324\/haematol.12949","article-title":"Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation","volume":"93","author":"Tichelli","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.001_bib0119","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","volume":"23","author":"Lyon","year":"2022","journal-title":"European Heart Journal-Cardiovascular Imaging"},{"key":"10.1016\/j.jtct.2023.12.001_bib0120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jaccao.2022.05.010","article-title":"Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy","volume":"4","author":"Aziz-Bose","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0121","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/bmt.2008.263","article-title":"High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation","volume":"43","author":"Majhail","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0122","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1158\/1055-9965.EPI-13-0610","article-title":"Impact of treatment exposures on cardiovascular risk and insulin resistance in childhood cancer survivors","volume":"22","author":"Baker","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jtct.2023.12.001_bib0123","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1038\/s41409-021-01414-7","article-title":"Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study","volume":"56","author":"Greenfield","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0124","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2010.06.001","article-title":"Cyclosporin A and atherosclerosis\u2013cellular pathways in atherogenesis","volume":"128","author":"Kockx","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0126","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bjh.12754","article-title":"Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort","volume":"165","author":"Nottage","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0127","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bbmt.2016.05.007","article-title":"Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT","volume":"22","author":"DeFilipp","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0128","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/bmt.2011.118","article-title":"Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation","volume":"47","author":"Baker","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0129","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bbmt.2011.08.003","article-title":"Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation","volume":"18","author":"Blaser","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exphem.2013.07.003","article-title":"Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events","volume":"42","author":"Pophali","year":"2014","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0131","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.bmt.1704996","article-title":"Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients","volume":"35","author":"Kyle","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0132","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jnci\/djz152","article-title":"Radiation Dose and Volume to the Pancreas and Subsequent Risk of Diabetes Mellitus: A Report from the Childhood Cancer Survivor Study","volume":"112","author":"Friedman","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2023.12.001_bib0133","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0134","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/bmt.2015.167","article-title":"Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study","volume":"50","author":"Oudin","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0135","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2006-10-054080","article-title":"Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation","volume":"110","author":"Tichelli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0136","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.31227","article-title":"Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation","volume":"124","author":"Leger","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0137","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbmt.2016.02.017","article-title":"Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors","volume":"22","author":"Leger","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0138","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/EDBK_100015","article-title":"Predicting and Preventing Anthracycline-Related Cardiotoxicity","volume":"38","author":"Armenian","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jtct.2023.12.001_bib0139","first-page":"606","article-title":"How we treat chronic graft-versus-host disease","volume":"125","author":"Flowers","year":"2015","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0140","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3109\/0284186X.2013.813636","article-title":"The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma","volume":"52","author":"Jorgensen","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0141","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00432-020-03500-7","article-title":"Secondary esophageal squamous cell carcinoma after hematopoietic stem cell transplantation","volume":"147","author":"Nomura","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0142","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jpedsurg.2017.06.022","article-title":"Surgical treatment of intestinal complications of graft versus host disease in the pediatric population: Case series and review of literature","volume":"52","author":"Gutierrez","year":"2017","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jtct.2023.12.001_bib0143","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/jnci\/djz060","article-title":"Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors","volume":"111","author":"Gini","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2023.12.001_bib0144","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/jnci\/djx266","article-title":"Colorectal Adenomas and Cancers After Childhood Cancer Treatment: A DCOG-LATER Record Linkage Study","volume":"110","author":"Teepen","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2023.12.001_bib0145","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.2011.37.8760","article-title":"Secondary colorectal carcinoma after childhood cancer","volume":"30","author":"Nottage","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0146","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/s41409-021-01258-1","article-title":"Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue","volume":"56","author":"Haghiri","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0147","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/bmt.2008.304","article-title":"Focal nodular hyperplasia of the liver following hematopoietic SCT","volume":"43","author":"Sudour","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0148","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/bmt.2014.276","article-title":"Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children","volume":"50","author":"Pillon","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0149","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/bmt.2009.336","article-title":"Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series","volume":"45","author":"Anderson","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0150","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2008-10-163493","article-title":"How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation","volume":"113","author":"Liang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0151","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1473-3099(16)00118-3","article-title":"Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)","volume":"16","author":"Mallet","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jtct.2023.12.001_bib0152","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.bbmt.2015.07.033","article-title":"Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations","volume":"21","author":"Torres","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0153","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.23533","article-title":"Hepatobiliary complications of hematopoietic cell transplantation, 40 years on","volume":"51","author":"McDonald","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0154","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bmt.1704429","article-title":"Acute pancreatitis due to tacrolimus in a case of allogeneic bone marrow transplantation","volume":"33","author":"Sastry","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1702769","article-title":"Pancreatic insufficiency in patients with chronic graft-versus-host disease","volume":"27","author":"Akpek","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0156","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1056\/NEJMra1404711","article-title":"Renal Complications of Hematopoietic-Cell Transplantation","volume":"374","author":"Hingorani","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0157","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2215\/CJN.10630917","article-title":"Changes in Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study","volume":"13","author":"Hingorani","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0158","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","article-title":"Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis","volume":"56","author":"Young","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0159","author":"Schoettler","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","article-title":"A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant","volume":"5","author":"Dandoy","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.001_bib0161","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/ajh.25922","article-title":"Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation","volume":"95","author":"Heybeli","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0162","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1651-2227.1995.tb13865.x","article-title":"Growth and endocrine disturbances after bone marrow transplantation in childhood","volume":"411","author":"Sklar","year":"1995","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.jtct.2023.12.001_bib0163","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0022-3476(97)80022-4","article-title":"Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation","volume":"130","author":"Brauner","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jtct.2023.12.001_bib0164","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/adc.67.9.1107","article-title":"Endocrine deficit after fractionated total body irradiation","volume":"67","author":"Ogilvy-Stuart","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jtct.2023.12.001_bib0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1515\/JPEM.1996.9.1.51","article-title":"Growth in children after bone marrow transplantation for acute myelogenous leukemia as compared to acute lymphocytic leukemia","volume":"9","author":"Alter","year":"1996","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jtct.2023.12.001_bib0166","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/edrv.19.2.0329","article-title":"The diagnosis of growth hormone deficiency in children and adults","volume":"19","author":"Shalet","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jtct.2023.12.001_bib0167","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000181036","article-title":"Growth and development in children after bone marrow transplantation","volume":"30","author":"Sanders","year":"1988","journal-title":"Horm Res"},{"key":"10.1016\/j.jtct.2023.12.001_bib0168","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood.V68.5.1129.1129","article-title":"Growth and development following marrow transplantation for leukemia","volume":"68","author":"Sanders","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0169","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0950-351X(05)80109-0","article-title":"Irradiation-induced growth failure","volume":"6","author":"Shalet","year":"1992","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2023.12.001_bib0170","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.bmt.1705455","article-title":"Final height and gonad function after total body irradiation during childhood","volume":"38","author":"Couto-Silva","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0171","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.bmt.1705694","article-title":"Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation","volume":"40","author":"Chemaitilly","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0172","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood-2004-07-2528","article-title":"Final adult height of patients who received hematopoietic cell transplantation in childhood","volume":"105","author":"Sanders","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0173","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","article-title":"Sex-Specific Cardiovascular Risks of Cancer and Its Therapies","volume":"130","author":"Wilcox","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jtct.2023.12.001_bib0174","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/leu.2010.210","article-title":"Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study","volume":"24","author":"Baker","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.12.001_bib0175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood-2008-08-173005","article-title":"Thyroid function following hematopoietic cell transplantation in children: 30 years' experience","volume":"113","author":"Sanders","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0176","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41409-018-0109-5","article-title":"Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes","volume":"53","author":"Farhadfar","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0177","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.leukres.2017.04.003","article-title":"Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"58","author":"Medinger","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.jtct.2023.12.001_bib0178","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbmt.2008.11.032","article-title":"Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies","volume":"15","author":"Savani","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0179","doi-asserted-by":"crossref","first-page":"506.e501","DOI":"10.1016\/j.jtct.2022.05.040","article-title":"Thyroid Disorders Following Hematopoietic Stem Cell Transplantation in Childhood: Impact of Conditioning Regimen on Thyroid Dysfunction, Volume Changes, and Occurrence of Nodules","volume":"28","author":"Cattoni","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0180","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.mph.0000132937.73264.55","article-title":"Thyrotoxicosis after matched unrelated bone marrow transplantation","volume":"26","author":"Tatevossian","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0181","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1200\/JCO.2011.38.4594","article-title":"Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation","volume":"30","author":"Khera","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0182","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/bmt.2011.169","article-title":"The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature","volume":"47","author":"Thygesen","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0183","first-page":"12","article-title":"Male Sexual Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Multicenter Study","author":"Haavisto","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtct.2023.12.001_bib0184","doi-asserted-by":"crossref","first-page":"80.e81","DOI":"10.1016\/j.bbmt.2020.09.027","article-title":"Sexual Functioning in Long-Term Survivors of Hematopoietic Cell Transplantation","volume":"27","author":"Syrjala","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejon.2014.12.005","article-title":"Patients' experience of sexuality 1-year after allogeneic Haematopoietic Stem Cell Transplantation","volume":"19","author":"N\u00f8rskov","year":"2015","journal-title":"European Journal of Oncology Nursing"},{"key":"10.1016\/j.jtct.2023.12.001_bib0186","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1182\/blood-2013-05-499806","article-title":"Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation","volume":"122","author":"Wong","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0187","first-page":"1693","article-title":"Sexuality and quality of life of patients with hematologic malignancy and hematopoietic stem cell transplantation: a critical review","volume":"25","author":"Tsatsou","year":"2020","journal-title":"J BUON"},{"key":"10.1016\/j.jtct.2023.12.001_bib0188","first-page":"4451","article-title":"Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis","volume":"27","author":"Gerstl","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0189","series-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","first-page":"421","article-title":"Endocrine Disorders, Fertility and Sexual Health","author":"Salooja","year":"2019"},{"key":"10.1016\/j.jtct.2023.12.001_bib0190","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.bbmt.2020.07.007","article-title":"Outcomes and Challenges of Reproductive Health in Hematopoietic Stem Cell Transplantation Survivors","volume":"26","author":"Bourlon","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0191","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2004.11.038","article-title":"Predicting age of ovarian failure after radiation to a field that includes the ovaries","volume":"62","author":"Wallace","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtct.2023.12.001_bib0192","first-page":"335.e317","volume":"28","author":"Phelan","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0193","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10815-020-01794-7","article-title":"Ovarian tissue cryopreservation as standard of care: what does this mean for pediatric populations?","volume":"37","author":"Nahata","year":"2020","journal-title":"Journal of assisted reproduction and genetics"},{"key":"10.1016\/j.jtct.2023.12.001_bib0194","article-title":"Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women","volume":"3","author":"Chen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtct.2023.12.001_bib0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/GRF.0000000000000448","article-title":"Uterine Factor Infertility: A Clinical Review","volume":"62","author":"Hur","year":"2019","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ctrv.2000.0193","article-title":"Pregnancy and radiation","volume":"27","author":"Fenig","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jtct.2023.12.001_bib0197","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jncimonographs\/lgi025","article-title":"Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data","author":"Meirow","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jtct.2023.12.001_bib0198","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0199","author":"Phelan","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1701575","article-title":"Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease","volume":"23","author":"Tse","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0201","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1703711","article-title":"Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation","volume":"30","author":"Couriel","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0202","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00005792-199609000-00004","article-title":"Polymyositis as a manifestation of chronic graft-versus-host disease","volume":"75","author":"Parker","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtct.2023.12.001_bib0203","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/rheumatology\/keg025","article-title":"Polymyositis as a manifestation of chronic graft-versus-host disease","volume":"42","author":"Stevens","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtct.2023.12.001_bib0204","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7326\/0003-4819-120-12-199406150-00004","article-title":"Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases","volume":"120","author":"Janin","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0205","first-page":"692","article-title":"Eosinophilic fasciitis after allogeneic bone marrow transplantation","volume":"17","author":"Markusse","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2008.297","article-title":"Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT","volume":"43","author":"Oda","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0207","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","article-title":"Glucocorticoid-induced myopathy","volume":"78","author":"Pereira","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jtct.2023.12.001_bib0208","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/bloodadvances.2019000918","article-title":"Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia","volume":"4","author":"Inamoto","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.001_bib0209","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.38293","article-title":"Assessment of joint and fascia manifestations in chronic graft-versus-host disease","volume":"66","author":"Inamoto","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0210","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3389\/fimmu.2020.02017","article-title":"Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation","volume":"11","author":"Buxbaum","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0211","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.bbmt.2020.07.001","article-title":"Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy","volume":"26","author":"Bar","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0212","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbmt.2007.01.085","article-title":"Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation","volume":"13","author":"Savani","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0213","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1210\/jc.2006-2870","article-title":"Bone loss and its management in long-term survivors from allogeneic stem cell transplantation","volume":"92","author":"Tauchmanova","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2023.12.001_bib0214","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bbmt.2016.04.012","article-title":"Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease","volume":"22","author":"Pirsl","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0215","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1703149","article-title":"Decreased bone mineral density is common after autologous blood or marrow transplantation","volume":"28","author":"Schimmer","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0216","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.bmt.1705918","article-title":"High prevalence of early-onset osteopenia\/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy","volume":"41","author":"Yao","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0217","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/TP.0b013e3181d84c8e","article-title":"Prospective assessment of bone turnover and clinical bone diseases after allogeneic hematopoietic stem-cell transplantation","volume":"89","author":"Petropoulou","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0218","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2001.v7.pm11400947","article-title":"Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study","volume":"7","author":"Stern","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0219","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/pbc.25370","article-title":"Bone loss and vitamin D deficiency in children undergoing hematopoietic cell transplantation","volume":"62","author":"Bechard","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0220","doi-asserted-by":"crossref","first-page":"44.e41","DOI":"10.1016\/j.jtct.2021.08.019","article-title":"Bone Health Outcomes at 1 Year after Hematopoietic Stem Cell Transplantation in a Heterogeneous Pediatric Population","volume":"28","author":"Swauger","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0221","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2003-09-3081","article-title":"Bone loss following hematopoietic stem cell transplantation: a long-term follow-up","volume":"103","author":"Schulte","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0222","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbmt.2010.02.017","article-title":"Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation","volume":"16","author":"Yao","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0223","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/bmt.2013.156","article-title":"Bone mineral deficits in recipients of hematopoietic cell transplantation: the impact of young age at transplant","volume":"49","author":"Petryk","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bmt.2010.198","article-title":"Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients","volume":"46","author":"McClune","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2011.10.007","article-title":"Bone loss and avascular necrosis of bone after hematopoietic cell transplantation","volume":"49","author":"McClune","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0226","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199111213252104","article-title":"Sickle cell disease as a cause of osteonecrosis of the femoral head","volume":"325","author":"Milner","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0227","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbmt.2013.12.567","article-title":"Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents","volume":"20","author":"Li","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0228","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00277-021-04480-5","article-title":"Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation","volume":"100","author":"Law","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0229","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/bloodadvances.2019001126","article-title":"Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia","volume":"4","author":"Lee","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.001_bib0230","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2141.1997.1262940.x","article-title":"Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM)","volume":"97","author":"Socie","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0231","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbmt.2010.03.008","article-title":"Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation","volume":"16","author":"McAvoy","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0232","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood-2011-04-314815","article-title":"How I conduct a comprehensive chronic graft-versus-host disease assessment","volume":"118","author":"Carpenter","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0233","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2006.02.003","volume":"12","author":"Couriel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0234","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1182\/blood-2018-04-785899","article-title":"How I treat refractory chronic graft-versus-host disease","volume":"133","author":"Sarantopoulos","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.68.1.36","article-title":"Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors","volume":"68","author":"de Brabander","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jtct.2023.12.001_bib0236","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/01.WNL.0000046522.38465.79","article-title":"Prospective evaluation of neurological complications after allogeneic bone marrow transplantation","volume":"60","author":"Sostak","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0237","doi-asserted-by":"crossref","first-page":"608.e601","DOI":"10.1016\/j.jtct.2022.06.009","article-title":"Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation Survivors","volume":"28","author":"Lehky","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0238","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/bmt.2017.239","article-title":"Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact","volume":"53","author":"Dowling","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0239","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00007890-200211150-00018","article-title":"Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients","volume":"74","author":"Pihusch","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0240","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2012.069559","article-title":"Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients","volume":"98","author":"Labrador","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.001_bib0241","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/bbmt.2001.v7.pm11302549","article-title":"Secondary failure of platelet recovery after hematopoietic stem cell transplantation","volume":"7","author":"Bruno","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0242","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/brain\/124.5.1043","article-title":"Stroke after bone marrow transplantation: frequency, aetiology and outcome","volume":"124","author":"Coplin","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jtct.2023.12.001_bib0243","series-title":"Stroke Risk in Blood or Marrow Transplant (BMT) Survivors-a Report from the BMT Survivor Study (BMTSS)","author":"Gangaraju","year":"2019"},{"key":"10.1016\/j.jtct.2023.12.001_bib0244","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000201014","article-title":"Consensus Recommendations for Managing Childhood Cancer Survivors at Risk for Stroke After Cranial Irradiation: A Delphi Study","author":"Kenney","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0245","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2007-0178","article-title":"Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group","volume":"120","author":"Gurney","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jtct.2023.12.001_bib0246","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood-2020-133895","article-title":"Severe\/Life-Threatening\/Fatal Chronic Health Conditions (CHCs) after Allogeneic Blood or Marrow Transplantation (BMT) in Childhood - a Report from the BMT Survivor Study (BMTSS)","volume":"136","author":"Holmqvist","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0247","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1188\/16.CJON.305-308","article-title":"Early Recognition and Management of Posterior Reversible Encephalopathy Syndrome: A Newly Recognized Complication in Patients Receiving Tyrosine Kinase Inhibitors","volume":"20","author":"Przybylyski","year":"2016","journal-title":"Clinical Journal of Oncology Nursing"},{"key":"10.1016\/j.jtct.2023.12.001_bib0248","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MPH.0000000000000521","article-title":"Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia","volume":"38","author":"Tavil","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0249","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1200\/JCO.2014.59.1586","article-title":"Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed\/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study","volume":"34","author":"Goebeler","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0250","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0251","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-201781","article-title":"Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab","volume":"2014","author":"Isidoro","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jtct.2023.12.001_bib0252","first-page":"1363","article-title":"[Targeted therapy and progressive multifocal leukoencephalopathy (PML): PML in the era of monoclonal antibody therapies]","volume":"65","author":"Takao","year":"2013","journal-title":"Brain Nerve"},{"key":"10.1016\/j.jtct.2023.12.001_bib0253","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/bmt.2015.76","article-title":"Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know","volume":"50","author":"Ogata","year":"2015","journal-title":"Bone marrow transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0254","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3324\/haematol.2010.029876","article-title":"Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents","volume":"96","author":"Schmidt-Hieber","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.001_bib0255","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1200\/JCO.2005.12.674","article-title":"Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls","volume":"23","author":"Syrjala","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0256","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2010.33.9119","article-title":"Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years","volume":"29","author":"Syrjala","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0257","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41409-017-0055-7","article-title":"Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT","volume":"53","author":"Buchbinder","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0258","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jtct.2022.06.027","article-title":"Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force","volume":"28","author":"Schofield","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0259","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJM198707163170314","article-title":"Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting","volume":"317","author":"Lefvert","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0260","article-title":"Thymoma in myasthenia gravis: from diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jtct.2023.12.001_bib0261","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1701575","article-title":"Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease","volume":"23","author":"Tse","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0262","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.intimp.2005.11.016","article-title":"The role of high-dose immune globulin intravenous in the treatment of dermatomyositis","volume":"6","author":"Dalakas","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0263","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thorax.56.1.82","article-title":"Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness","volume":"56","author":"Stephenson","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.jtct.2023.12.001_bib0264","first-page":"58","article-title":"Polymyositis After Bone Marrow Transplantation: As an Uncommon Manifestation of Chronic Graft-Versus-Host Disease? or Autoimmune Process?","volume":"13","author":"Choi","year":"2011","journal-title":"Annals of Clinical Neurophysiology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0265","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2169\/internalmedicine.48.2003","article-title":"Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation","volume":"48","author":"Matsuo","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0266","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/bmt.2009.323","article-title":"Cerebral angiitis in four patients with chronic GVHD","volume":"45","author":"Sostak","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0267","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/brain\/awq245","article-title":"Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease","volume":"133","author":"Grauer","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jtct.2023.12.001_bib0268","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1182\/blood-2011-04-348730","article-title":"Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS)","volume":"118","author":"Sun","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0269","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood-2006-02-003954","article-title":"Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study","volume":"108","author":"Fraser","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0270","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpainsymman.2017.07.012","article-title":"Stability and Priority of Symptoms and Symptom Clusters Among Allogeneic HSCT Patients Within a 5-Year Longitudinal Study","volume":"54","author":"Esser","year":"2017","journal-title":"Journal of pain and symptom management"},{"key":"10.1016\/j.jtct.2023.12.001_bib0271","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/bmt.2016.344","article-title":"Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT","volume":"52","author":"Esser","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0272","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11764-016-0579-7","article-title":"Posttraumatic stress disorder symptomatology in the course of allogeneic HSCT: a prospective study","volume":"11","author":"Esser","year":"2017","journal-title":"Journal of Cancer Survivorship"},{"key":"10.1016\/j.jtct.2023.12.001_bib0273","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/bmt.2017.190","article-title":"Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany","volume":"52","author":"Kuba","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0274","first-page":"1357","article-title":"Quality of life concerns and depression among hematopoietic stem cell transplant survivors","volume":"19","author":"Mosher","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0275","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.2005.03.189","article-title":"Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation","volume":"23","author":"Andrykowski","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0276","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11899-022-00678-0","article-title":"Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation","volume":"17","author":"Bhatt","year":"2022","journal-title":"Current hematologic malignancy reports"},{"key":"10.1016\/j.jtct.2023.12.001_bib0277","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.291.19.2335","article-title":"Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma","volume":"291","author":"Syrjala","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2023.12.001_bib0278","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S1083-8791(00)70067-X","article-title":"Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: A longitudinal follow-up of 415 patients","volume":"6","author":"Bush","year":"2000","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0279","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/bmt.2017.115","article-title":"Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation","volume":"52","author":"Tichelli","year":"2017","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0280","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/bmt.2008.253","article-title":"Quality of life and social integration after allogeneic hematopoietic SCT","volume":"42","author":"Bieri","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0281","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1182\/blood-2009-06-225631","article-title":"Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns","volume":"115","author":"Wong","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0282","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s002770000249","article-title":"Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation","volume":"80","author":"Heinonen","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0283","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.bbmt.2016.05.013","article-title":"Employment Status as an Indicator of Recovery and Function One Year after Hematopoietic Stem Cell Transplantation","volume":"22","author":"Morrison","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0284","doi-asserted-by":"crossref","first-page":"679.e671","DOI":"10.1016\/j.jtct.2021.04.013","article-title":"Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States","volume":"27","author":"Bhatt","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0285","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.bbmt.2017.07.024","article-title":"Ascertainment of Unmet Needs and Participation in Health Maintenance and Screening of Adult Hematopoietic Cell Transplantation Survivors Followed in a Formal Survivorship Program","volume":"23","author":"Hahn","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0286","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/bmt.2011.107","article-title":"Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30","volume":"47","author":"Grulke","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0287","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1399-3046.2011.01537.x","article-title":"The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood","volume":"15","author":"Lof","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0288","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.687675","article-title":"\"This Graft-vs.-Host Disease Determines My Life. That's It.\"-A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany","volume":"9","author":"Parisek","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.jtct.2023.12.001_bib0289","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/bmt.2014.166","article-title":"Quality of life and outcomes in patients\u2a7e60 years of age after allogeneic hematopoietic cell transplantation","volume":"49","author":"Hamilton","year":"2014","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0290","first-page":"249","article-title":"The long-term psychosocial effects of haematopoetic stem cell transplantation","volume":"12","author":"Gruber","year":"2003","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.jtct.2023.12.001_bib0291","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41409-018-0343-x","article-title":"Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey","volume":"54","author":"Kurosawa","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0292","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbmt.2017.10.009","article-title":"Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes","volume":"24","author":"Hamilton","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0293","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bmt.1703677","article-title":"Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation","volume":"30","author":"Worel","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0294","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.3324\/haematol.2019.225326","article-title":"Mental fatigue after allogeneic hematopoietic stem cell transplantation is associated with cognitive dysfunction, but not central nervous system inflammation","volume":"105","author":"Boberg","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.001_bib0295","unstructured":"!!! INVALID CITATION !!! ."},{"key":"10.1016\/j.jtct.2023.12.001_bib0296","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/bmt.2016.107","article-title":"Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma","volume":"51","author":"Hong","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0297","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbmt.2016.08.016","article-title":"Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial","volume":"22","author":"Knight","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0298","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0299","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/bmt.2016.113","article-title":"Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN","volume":"51","author":"Shaw","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0300","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.30936","article-title":"Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful","author":"Shaw","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0301","series-title":"NCCN Guidelines Version 2","year":"2021"},{"key":"10.1016\/j.jtct.2023.12.001_bib0302","unstructured":"The NCCN survivorship guidelines (version 3.2021)"},{"key":"10.1016\/j.jtct.2023.12.001_bib0303","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12955-019-1231-9","article-title":"Parent proxy assessment of sibling quality of life following pediatric hematopoietic cell transplantation","volume":"17","author":"Buchbinder","year":"2019","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jtct.2023.12.001_bib0304","doi-asserted-by":"crossref","first-page":"e13003","DOI":"10.1111\/petr.13003","article-title":"Post-traumatic stress disorder and health-related quality of life in the siblings of the pediatric bone marrow transplantation survivors and post-traumatic stress disorder in their mothers","volume":"21","author":"Gizli Coban","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0305","first-page":"591","article-title":"Correlates of anxiety and depression symptoms among patients and their family caregivers prior to allogeneic hematopoietic cell transplant for hematological malignancies","volume":"27","author":"Posluszny","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0306","first-page":"2329","article-title":"Distress and quality of life in patient and caregiver dyads facing stem cell transplant: identifying overlap and unique contributions","volume":"27","author":"Sannes","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0307","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.bbmt.2020.04.022","article-title":"Return-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplantation Survivors: An Initial Survey","volume":"26","author":"Salit","year":"2020","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0308","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jtct.2022.09.017","article-title":"American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee Recommendations for Health Care Providers Who Take Care of Hematopoietic Cell Transplantation Patients","volume":"28","author":"Salit","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0309","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.bbmt.2011.10.005","article-title":"Subsequent malignant neoplasms after hematopoietic cell transplantation","volume":"18","author":"Socie","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0310","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood-2002-04-1261","article-title":"Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study","volume":"101","author":"Metayer","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0311","first-page":"1302","article-title":"How I monitor long-term and late effects after blood or marrow transplantation","volume":"130","author":"Bhatia","year":"2017","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0312","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4161\/cbt.26342","article-title":"Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients","volume":"14","author":"Akhtari","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0313","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2010.10.010","article-title":"Donor cell leukemia: a review","volume":"17","author":"Wiseman","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0314","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/s41409-021-01214-z","article-title":"Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome","volume":"56","author":"Williams","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0315","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.leukres.2018.07.016","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma","volume":"74","author":"Radivoyevitch","year":"2018","journal-title":"Leuk Res"},{"key":"10.1016\/j.jtct.2023.12.001_bib0316","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.2010.28.9777","article-title":"Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma","volume":"29","author":"Tarella","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0317","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/bloodadvances.2019001157","article-title":"Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation","volume":"4","author":"Soerensen","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.001_bib0318","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41408-021-00454-y","article-title":"Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma","volume":"11","author":"Nadiminti","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2023.12.001_bib0319","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0320","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines","volume":"101","author":"Styczynski","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.001_bib0321","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bmt.2014.13","article-title":"Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study","volume":"49","author":"Bilmon","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0322","first-page":"146","article-title":"Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood","volume":"2","author":"Bomken","year":"2015","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jtct.2023.12.001_bib0323","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2006.08.9276","article-title":"Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study","volume":"25","author":"Cohen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0324","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12185-020-02991-x","article-title":"Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis","volume":"113","author":"Yabe","year":"2021","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0325","doi-asserted-by":"crossref","first-page":"e13706","DOI":"10.1111\/petr.13706","article-title":"Squamous cell carcinoma development in Fanconi anemia patients who underwent hematopoietic stem cell transplantation","volume":"24","author":"Anak","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0326","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11864-018-0528-y","article-title":"Second Malignancies after Hematopoietic Stem Cell Transplantation","volume":"19","author":"Danylesko","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0327","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.bbmt.2014.07.009","article-title":"Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning","volume":"20","author":"Ringden","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0328","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/bmt.2017.4","article-title":"Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Tanaka","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0329","doi-asserted-by":"crossref","first-page":"E1159","DOI":"10.1097\/MPH.0000000000002152","article-title":"Case Series: Development of Polyps as a Late Effect After Total Body Irradiation-based Hematopoietic Cell Transplantation in Children With High-risk Leukemia","volume":"43","author":"Knight","year":"2021","journal-title":"Journal of Pediatric Hematology Oncology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0330","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1016\/S1470-2045(13)70303-6","article-title":"Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"14","author":"Mulder","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0331","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast cancer after chest radiation therapy for childhood cancer","volume":"32","author":"Moskowitz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0332","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1200\/JCO.20.00231","article-title":"Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report","volume":"38","author":"McDonald","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0333","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2022.01.001","article-title":"Male breast cancer after childhood cancer: Systematic review and analyses in the PanCareSurFup cohort","volume":"165","author":"Wang","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0334","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/bjc.2017.169","article-title":"Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Moskowitz","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0335","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.20.00562","article-title":"Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group","volume":"38","author":"Mulder","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0336","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.17219\/acem\/126739","article-title":"Secondary skin neoplasms in patients after autologous and allogeneic hematopoietic stem cell transplantation procedures","volume":"29","author":"Szlauer-Stefanska","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0337","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaad.2019.10.034","article-title":"Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation","volume":"83","author":"Herr","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0338","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1016\/S1470-2045(13)70107-4","article-title":"Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review","volume":"14","author":"Bowers","year":"2013","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0339","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.bmt.1701407","article-title":"Meningioma in long-term survivors after allogeneic bone marrow transplantation","volume":"22","author":"Meignin","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0340","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2012.47.0500","article-title":"Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia","volume":"31","author":"Schmiegelow","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0341","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/bmt.2012.166","article-title":"Second malignancies after autologous hematopoietic cell transplantation in children","volume":"48","author":"Danner-Koptik","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0342","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bmt.2015.63","article-title":"Secondary solid cancer screening following hematopoietic cell transplantation","volume":"50","author":"Inamoto","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0343","series-title":"FACT-JACIE International Standards for Hemopoietic Cellular Therapy Product Collection, Processing, and Administration","year":"2018"},{"key":"10.1016\/j.jtct.2023.12.001_bib0344","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1043454217723864","article-title":"Facilitators and Barriers to Self-Management for Adolescents and Young Adults Following a Hematopoietic Stem Cell Transplant [Formula: see text]","volume":"35","author":"Morrison","year":"2018","journal-title":"Journal of pediatric oncology nursing: official journal of the Association of Pediatric Oncology Nurses"},{"key":"10.1016\/j.jtct.2023.12.001_bib0345","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbmt.2015.12.019","article-title":"What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia","volume":"22","author":"Dyer","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0346","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41409-019-0748-1","article-title":"Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults","volume":"55","author":"Majhail","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0347","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.bbmt.2018.03.023","article-title":"ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors","volume":"24","author":"Hashmi","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0348","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jtct.2022.02.003","article-title":"Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes","volume":"28","author":"Kapadia","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0349","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/bmt.2011.60","article-title":"Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study","volume":"47","author":"Armenian","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0350","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.12688\/f1000research.15633.1","article-title":"Inadequate survivorship care after allogeneic hematopoietic cell transplantation: A retrospective chart review","volume":"7","author":"Thaw","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.jtct.2023.12.001_bib0351","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3324\/haematol.2018.203919","article-title":"Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors","volume":"104","author":"Majhail","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.001_bib0352","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11764-018-0693-9","article-title":"An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation","volume":"12","author":"Syrjala","year":"2018","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.jtct.2023.12.001_bib0353","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.bbmt.2020.02.004","article-title":"Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation","volume":"26","author":"Nawas","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0354","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbmt.2020.02.027","article-title":"Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease","volume":"26","author":"Chang","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0355","doi-asserted-by":"crossref","first-page":"181.e181","DOI":"10.1016\/j.jtct.2020.10.017","article-title":"Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients","volume":"27","author":"Racioppi","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0356","first-page":"8045","article-title":"Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth-the SMILe study","volume":"29","author":"Leppla","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0357","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.bbmt.2018.05.004","article-title":"Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors","volume":"24","author":"Syrjala","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0358","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2020.101723","article-title":"Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: A mixed-methods contextual analysis as part of the SMILe study","volume":"45","author":"Leppla","year":"2020","journal-title":"European journal of oncology nursing: the official journal of European Oncology Nursing Society"},{"key":"10.1016\/j.jtct.2023.12.001_bib0359","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/er.2018-00006","article-title":"Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints","volume":"40","author":"Chang","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jtct.2023.12.001_bib0360","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood.2021011488","article-title":"Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither","volume":"138","author":"Jones","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0361","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41467-022-28762-2","article-title":"A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders","volume":"13","author":"Tucci","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtct.2023.12.001_bib0362","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/ejh.13169","article-title":"Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation","volume":"101","author":"Jarisch","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0363","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.2337\/dc20-0908","article-title":"The Close Link of Pancreatic Iron With Glucose Metabolism and With Cardiac Complications in Thalassemia Major: A Large, Multicenter Observational Study","volume":"43","author":"Pepe","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtct.2023.12.001_bib0364","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102296","article-title":"Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group","volume":"100","author":"Bardi","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jtct.2023.12.001_bib0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238793","article-title":"Outcome of iron reduction therapy in ex-thalassemics","volume":"16","author":"Aboobacker","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2023.12.001_bib0366","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/JCO.2014.59.7351","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014","volume":"33","author":"Lyman","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0367","series-title":"IMWG guidelines for the prevention of thalidomide and lenalidomide-associated thrombosis in myeloma","year":"2022"},{"key":"10.1016\/j.jtct.2023.12.001_bib0368","first-page":"281","article-title":"Commentary: Is Immune Recovery-Based Post-Transplantation Vaccination in Children Better Than Time-Based Revaccination?","volume":"27","author":"Carpenter","year":"2021","journal-title":"Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy"},{"key":"10.1016\/j.jtct.2023.12.001_bib0369","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report","volume":"27","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0370","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0371","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/cncr.20762","article-title":"Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children","volume":"103","author":"H\u00f6ltt\u00e4","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0372","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/bmt.2011.35","article-title":"Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD","volume":"46","author":"Hildebrandt","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0373","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1111\/ajt.15814","article-title":"Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"20","author":"Cheng","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0374","doi-asserted-by":"crossref","first-page":"328.e321","DOI":"10.1016\/j.jtct.2022.02.002","article-title":"Multiple Breath Washout Testing to Identify Pulmonary Chronic Graft Versus Host Disease in Children After Hematopoietic Stem Cell Transplantation","volume":"28","author":"Rayment","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0375","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbmt.2019.12.002","article-title":"Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation","volume":"26","author":"Jamani","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0376","doi-asserted-by":"crossref","first-page":"616.e611","DOI":"10.1016\/j.jtct.2021.03.024","article-title":"Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease","volume":"27","author":"Turner","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.001_bib0377","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1513\/AnnalsATS.201604-262OC","article-title":"Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant","volume":"13","author":"Cheng","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jtct.2023.12.001_bib0378","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbmt.2017.01.075","volume":"23","author":"Dietz","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0379","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1249\/MSS.0b013e3181e0c112","article-title":"American College of Sports Medicine roundtable on exercise guidelines for cancer survivors","volume":"42","author":"Schmitz","year":"2010","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jtct.2023.12.001_bib0380","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/bmt.2016.203","article-title":"Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT","volume":"52","author":"DeFilipp","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0381","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jtct.2023.12.001_bib0382","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0383","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamaoncol.2018.6634","article-title":"Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity","volume":"5","author":"Feijen","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0384","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0385","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Survivorship. Vol 2022. Version 1.2022 ed2022."},{"key":"10.1016\/j.jtct.2023.12.001_bib0386","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0387","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/cid\/civ344","article-title":"Monitoring of hepatitis B virus (HBV) DNA and risk of HBV reactivation in B-cell lymphoma: a prospective observational study","volume":"61","author":"Kusumoto","year":"2015","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jtct.2023.12.001_bib0388","first-page":"11","article-title":"HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review","author":"Gentile","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jtct.2023.12.001_bib0389","unstructured":"AASLD\/IDSA\/IASeUSA. Recommendations for testing, managing, and treating hepatitis C."},{"key":"10.1016\/j.jtct.2023.12.001_bib0390","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0391","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ecl.2007.07.002","article-title":"Endocrine complications of hematopoietic stem cell transplantation","volume":"36","author":"Chemaitilly","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jtct.2023.12.001_bib0392","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ecl.2007.07.002","article-title":"Endocrine Complications of Hematopoietic Stem Cell Transplantation","volume":"36","author":"Chemaitilly","year":"2007","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.jtct.2023.12.001_bib0393","series-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","first-page":"421","article-title":"Endocrine Disorders, Fertility and Sexual Health","author":"Salooja","year":"2019"},{"key":"10.1016\/j.jtct.2023.12.001_bib0394","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2007-06-096594","article-title":"Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years","volume":"111","author":"Syrjala","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0395","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/cncr.31333","article-title":"Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation","volume":"124","author":"El-Jawahri","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0396","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11764-010-0132-z","article-title":"Psychological interventions for the sexual sequelae of cancer: a review of the literature","volume":"4","author":"Brotto","year":"2010","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.jtct.2023.12.001_bib0397","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1089\/jayao.2020.0012","article-title":"Standardizing Risk Assessment for Treatment-Related Gonadal Insufficiency and Infertility in Childhood Adolescent and Young Adult Cancer: The Pediatric Initiative Network Risk Stratification System","volume":"9","author":"Meacham","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0398","first-page":"138","article-title":"Bone Densitometry in Children and Adolescents","author":"Bachrach","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jtct.2023.12.001_bib0399","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2006-1178","article-title":"Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry","volume":"91","author":"Lewiecki","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtct.2023.12.001_bib0400","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11657-018-0453-5","article-title":"Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation","volume":"13","author":"Pundole","year":"2018","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.jtct.2023.12.001_bib0401","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/bmt.2016.312","article-title":"Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis","volume":"52","author":"Pundole","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.001_bib0402","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1200\/JCO.2017.76.6402","article-title":"Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"36","author":"Anderson","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0403","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13023-020-01644-w","article-title":"Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)","volume":"16","author":"Guffon","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtct.2023.12.001_bib0404","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/gim.2018.29","article-title":"Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison","volume":"20","author":"Eisengart","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jtct.2023.12.001_bib0405","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2011.10.007","article-title":"Bone loss and avascular necrosis of bone after hematopoietic cell transplantation","volume":"49","author":"McClune","year":"2012","journal-title":"Seminars in hematology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0406","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2016-05-715342","article-title":"Genetic risk factors for sclerotic graft-versus-host disease","volume":"128","author":"Inamoto","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0407","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0408","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10875-020-00857-9","article-title":"Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry","volume":"40","author":"Kuo","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2023.12.001_bib0409","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/hematology.2020000095","article-title":"Special pre- and posttransplant considerations in inherited bone marrow failure and hematopoietic malignancy predisposition syndromes","volume":"2020","author":"Bonfim","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2023.12.001_bib0410","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.2018874115","article-title":"Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation","volume":"133","author":"Baker","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0411","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/bmt.2017.4","article-title":"Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Tanaka","year":"2017","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2023.12.001_bib0412","article-title":"Breast Cancer Risk Reduction","volume":"2021","year":"2021","journal-title":"NCCN Clinical Practice Guidelines in Oncology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0413","article-title":"Breast Cancer Risk Reduction: who, why and what?","author":"Bozzuto","year":"2021","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"key":"10.1016\/j.jtct.2023.12.001_bib0414","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2017.11.005","volume":"63","author":"Clement","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jtct.2023.12.001_bib0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2006.043257","article-title":"Clinical and molecular features associated with biallelic mutations in FANCD1\/BRCA2","volume":"44","author":"Alter","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.jtct.2023.12.001_bib0416","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/pbc.23168","article-title":"The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1\/BRCA2 mutations","volume":"58","author":"Myers","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.12.001_bib0417","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer","volume":"39","author":"Reid","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtct.2023.12.001_bib0418","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2003-09-3138","article-title":"Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia","volume":"103","author":"Wagner","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.001_bib0419","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","article-title":"Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome","volume":"23","author":"Kratz","year":"2017","journal-title":"Clin Cancer Res"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672301713X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672301713X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:12:32Z","timestamp":1763003552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672301713X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":419,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S266663672301713X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.12.001","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Dr. Seth J Rotz*. Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}